Professor | Jun Zhang | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Jun Zhang

Contact Information

junzhang@bjmu.edu.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2001 - PhD in Immunology from Peking University 2001-2004 - Postdoctoral Research in Immunology at the Jewish Medical Center, USA Funded projects include Ministry of Science and Technology '863' project, 5 National Natural Science Foundation projects, and more
Work Experience	2004-present - Peking University, Faculty of Medicine: Associate Professor, Professor
Awards	2013 - Ministry of Education New Century Excellent Talents 2014 - Peking University Outstanding Young Talent Award Various teaching and research awards at Peking University

University/Lab Affiliation and Title

Peking University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2001 - PhD in Immunology from Peking University
2001-2004 - Postdoctoral Research in Immunology at the Jewish Medical Center, USA
Funded projects include Ministry of Science and Technology '863' project, 5 National Natural Science Foundation projects, and more

Work Experience

2004-present - Peking University, Faculty of Medicine: Associate Professor, Professor

Awards

Areas of Focus	Inflammation regulation and cancer immunology
Publications	USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling, Jun Zhang, 2018 PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision, Jun Zhang, 2018 Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell, Jun Zhang, 2018 Inflammasomes in Inflammation-Induced Cancer, Jun Zhang, 2017 Smurf2 negatively modulates RIG-I-dependent anti-viral response by targeting VISA/MAVS for ubiquitination and degradation, Jun Zhang, 2014 The tumor suppressive function of UNC5D and its repressed expression in renal cell carcinoma, Jun Zhang, 2013 PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3, Jun Zhang, 2013 Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma, Jun Zhang, 2011 CHP2 activates the calcineurin/NFAT signaling pathway and enhances the oncogenic potential of HEK293 cells, Jun Zhang*, 2008

Areas of Focus

Inflammation regulation and cancer immunology

Publications

USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling, Jun Zhang*, 2018
PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision, Jun Zhang*, 2018
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell, Jun Zhang*, 2018
Inflammasomes in Inflammation-Induced Cancer, Jun Zhang*, 2017
Smurf2 negatively modulates RIG-I-dependent anti-viral response by targeting VISA/MAVS for ubiquitination and degradation, Jun Zhang*, 2014
The tumor suppressive function of UNC5D and its repressed expression in renal cell carcinoma, Jun Zhang*, 2013
PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3, Jun Zhang*, 2013
Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma, Jun Zhang*, 2011
CHP2 activates the calcineurin/NFAT signaling pathway and enhances the oncogenic potential of HEK293 cells, Jun Zhang*, 2008

Inflammation Immunology Cancer Regulation Tumor Immune Response Cell Signaling Molecular Biology Pathogenesis Therapy

Zhuang Hui - Peking University

Fu Yi - Peking University

Bai Yun - Peking University

View All

Personal Information